COLLAGENEX PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
FDA-approved drugs
openFDA · most recent- PERIOSTATSep 30, 1998
Material events
SEC Form 8-K · most recent- Delisting / listing-standard notice · Change in control · Director / officer change · Amended charter or bylawsApr 18, 2008
- Results of operations · Other material eventMar 12, 2008
- Entered a material agreement · Other material eventFeb 27, 2008
- Results of operationsNov 6, 2007
- Other material eventSep 26, 2007
- Results of operationsAug 7, 2007
- Terminated a material agreementMay 25, 2007
- Entered a material agreementMay 18, 2007
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 13, 2009
- EFFECTJul 2, 2008
- POS AMJul 1, 2008
- SC 13G/AST - GETOUT - MSMay 13, 2008
- NO ACTAUTO-GENERATED PAPER DOCUMENTMay 12, 2008
- NO ACTAUTO-GENERATED PAPER DOCUMENTMay 12, 2008
- NO ACTAUTO-GENERATED PAPER DOCUMENTMay 12, 2008
- NO ACTAUTO-GENERATED PAPER DOCUMENTMay 12, 2008
- NO ACTAUTO-GENERATED PAPER DOCUMENTMay 12, 2008
- NO ACTAUTO-GENERATED PAPER DOCUMENTMay 12, 2008
- 15-12GFORM 15May 12, 2008
- SC 13G/ACOLLAGENEX PHARMACEUTICALS 13GA2May 9, 2008
- EFFECTMay 8, 2008
- POS AMMay 8, 2008
- EFFECTApr 28, 2008
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.